financetom
Business
financetom
/
Business
/
Ferrari is sued by US drivers over brake defect
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ferrari is sued by US drivers over brake defect
Mar 19, 2024 7:27 AM

(Reuters) - Ferrari ( RACE ) has been sued in the United States by drivers who said the Italian luxury sports car maker has failed to fix vehicles at risk of a partial or total loss of braking capability.

According to a proposed class action filed on Monday in San Diego federal court, recalls in 2021 and 2022 to address leaking brake fluid were only an interim measure, allowing Ferrari ( RACE ) to keep selling thousands of cars with defective brakes.

The complaint said the only fix was to replace defective master cylinders when leaks are found.

"Ferrari ( RACE ) was legally required to disclose the brake defect as a known safety defect and failed to do so," according to the complaint, which sought unspecified damages for drivers.

In a statement on Tuesday, Ferrari ( RACE ) did not specifically address the lawsuit but said its "highest priority" was the safety and well-being of its drivers.

"We operate according to stringent safety and security guidelines to ensure that our vehicles always respect homologation specifications," Ferrari ( RACE ) added.

The lawsuit is led by Iliya Nechev, a San Marcos, California resident who bought his 2010 Ferrari ( RACE ) 458 Italia in 2020.

Nechev said he "came close to an accident several times" because of his Ferrari's ( RACE ) brakes, but his dealership said they were "normal" and he should "just get used to them." He said he wouldn't have bought his Ferrari ( RACE ) had he known of the problems.

Ferrari ( RACE ) issued brake recalls in several countries including the United States and China starting in October 2021.

The U.S. recalls covered many Ferrari ( RACE ) models, including versions of the 458 and 488, produced over nearly two decades.

Ferrari and Robert Bosch, the German supplier of the alleged defective parts, have said problems could result from brake reservoir fluid caps that might not vent properly, potentially creating a vacuum inside the fluid reservoir.

Bosch is also a defendant. It did not immediately respond on Tuesday to a request for comment. The five law firms that represent Nechev did not immediately respond to requests for additional comment.

The case is Nechev v. Ferrari North America Inc et al, U.S. District Court, Southern District of California, No. 24-00516.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Entergy to Pay Quarterly Dividend of $0.60 a Share, Payable June 2 to Shareholders of Record May 2
--Entergy to Pay Quarterly Dividend of $0.60 a Share, Payable June 2 to Shareholders of Record May 2
Apr 7, 2025
12:14 PM EDT, 04/07/2025 (MT Newswires) -- Price: 78.36, Change: -0.67, Percent Change: -0.85 ...
Westinghouse Air Brake Technologies Insider Sold Shares Worth $9,831,177, According to a Recent SEC Filing
Westinghouse Air Brake Technologies Insider Sold Shares Worth $9,831,177, According to a Recent SEC Filing
Apr 7, 2025
12:15 PM EDT, 04/07/2025 (MT Newswires) -- Rafael Santana, Director, President and CEO, on April 03, 2025, sold 55,942 shares in Westinghouse Air Brake Technologies ( WAB ) for $9,831,177. Following the Form 4 filing with the SEC, Santana has control over a total of 145,616 common shares of the company, with 145,616 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/943452/000094345225000106/xslF345X05/wk-form4_1744042154.xml Price:...
Novo Nordisk to invest $1.09 billion to boost Ozempic, Wegovy production in Brazil
Novo Nordisk to invest $1.09 billion to boost Ozempic, Wegovy production in Brazil
Apr 7, 2025
SAO PAULO, April 7 (Reuters) - Novo Nordisk, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil to boost production, it said on Monday. The investment aims to increase manufacturing capacity at Novo Nordisk's facility in Minas Gerais state for injectable drugs for the treatment of obesity, diabetes and other serious chronic...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved